What is Precision Oncology Ireland?
Precision Oncology Ireland (POI) is a consortium of 5 Irish Universities, 6 Irish Charities, and 7 industry partners aiming to develop new diagnostics and therapeutics for personalised cancer treatment. Officially launched in November 2019, the consortium is part-funded by Taighde Éireann – Research Ireland under their Strategic Partnership Programme, and is co-ordinated by Systems Biology Ireland.
Leadership
POI is led by Prof. Walter Kolch, Director of Systems Biology Ireland in UCD, and a leading international proponent of precision medicine. The Deputy Director is Prof. William Gallagher, Professor of Cancer Biology in UCD Conway Institute.
Partnership
The combined Research-Ireland, charity, and industrial funding commitment has exceeded €10 million over the past five years. This is the first time that researchers, charities and industry have combined forces in this way, with a joint view of achieving greater impact for patients by uniting investments in the POI programme.
